Two trades to watch: Dax, Nasdaq
Fiona Cincotta February 3, 2021 7:13 PM
Dax rises on global recovery hopes. Nasdaq futures return to ascending channel after Amazon & Alphabet beat forecasts.
Dax rises on global recovery optimism
Dax technical analysis
The DAX has been trending lower since early January, before rebounding off 13270.
The Dax price has extended its recovery through the 50 and 100 sma on the 4 hour chart and has also moved above the descending trend line negating the near term bearish trend.
The RSI is supportive of further upside, sitting over 50 and pointing northwards but still below overbought territory.
Immediate resistance is seen at 14000 and a move above this level could see the Dax gain traction towards its all time high of 14137.
Nasdaq futures advance after Amazon & Alphabet results
The Nasdaq resumed its upward trajectory as the focus shifts back to earnings and away from the retail trader short squeeze frenzy of last week.
Alphabet and Amazon posted impressive Q4 earnings besting on both the top & bottom line, rising 7.7% and 1.3% respectively helping to lift Nasdaq futures.
US vaccination drive is picking up pace with 32.2 million people vaccinated.
US ADP data coming up
Nasdaq technical analysis
After rebounding off its 50 sma on the daily chart, the Nasdaq has returned to its ascending channel. The bull trend remains firmly intact and is well supported by the 50 sma. The RSI is also in bullish territory and indicative of further gains at 62.
Immediate resistance can be seen at 13610 all time high reached last week before 13775 the upper band of the ascending trendline is tested and the bulls target 14000 round number.
On the downside, 13120 the lower ban of the ascending channel offers support ahead of the 50 sma at 12800.
To read more on the outlook of tech stocks across the coming year click here
From time to time, StoneX Financial Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.